Conservative management of osteomyelitis in the feet of diabetic patients

Diabetic Medicine

Volumn 14, Issue 6, 1997, Pages 487-490

  Venkatesan, P ^a   Lawn, S ^a   Macfarlane, R M ^a   Fletcher, E M ^a   Finch, R G ^a   Jeffcoate, W J ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Complications; Diabetes mellitus; Foot infection; Osteomyelitis

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; FUSIDATE SODIUM; GENTAMICIN; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DIABETIC FOOT; FEMALE; FOOT AMPUTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; OSTEOMYELITIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BONE AND BONES; CLINDAMYCIN; DIABETIC FOOT; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES; SOFT TISSUE INFECTIONS; TOES; TREATMENT OUTCOME;

EID: 0030743919     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199706)14:6<487::AID-DIA373>3.0.CO;2-Q     Document Type: Article

References (14)

1. Newman LG, Waller J, Palestro CJ, Schwartz M, Klein MJ, Hermann G, et al. Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinolone. J Am Med Assoc 1991; 266: 1246-1451.
2. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med 1989; 149: 2262-2266.
3. Grayson ML, Gibbons GW, Balogh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. J Am Med Assoc 1995; 273: 721-723.
4. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. New Engl J Med 1994; 331: 854-860.
5. Brower AC. What is the preferred method of diagnosing osteomyelitis in the foot of a patient with diabetes? Amer J Roentgenol 1994; 163: 471-472.
6. Jeffcoate WJ, Macfarlane RM. In: The Diabetic Foot: an Illustrated Guide to Management. London: Chapman & Hall 1995, 39-43.
7. Eckman MH, Greenfield S, Mackey WC, Wong JB, Kaplan S, Sullivan L, et al. Foot infections in diabetic patients: decision and cost-effectiveness analysis. J Am Med Assoc 1995; 273: 712-720.
8. Wilson KH, Kauffman CA. Oral antibiotic therapy for osteomyelitis of the foot in diabetic patients. South Med J 1985; 78: 223-224.
9. Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients: long term results, prognostic factors, and the role of antimicrobial and surgical therapy. Amer J Med 1987; 83: 653-660.
10. Peterson LR, Lissack LM, Canter K, Fasching CE, Clabots C, Gerding DN. Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus. Amer J Med 1989; 86: 801-808.
11. Jeffcoate WJ, Jones EW, Peacock I, Finch RG. The significance of infection in diabetic foot lesions. In: Connor H, Boulton AJM, Ward JD, eds. The Foot in Diabetes, 1st edn. Chichester: Wiley, 1987: 59-68.
12. Hunt JA. Foot infections in diabetes are rarely due to a single microorganism. Diabetic Med 1992; 9: 749-752.
13. Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 1982; 23: 373-380.
14. Easmo CS, Crane JP. Uptake of ciprofloxacin by human neutrophils. J Antimicrob Chemother 1985; 16: 67-73.